Roche signs licensing and settlement agreements for Hepatitis C immunodiagnostics
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Novo Nordisk celebrates first ever UN-observed World Diabetes Day
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
Novel agent for treatment of Parkinson's disease in clinical development
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
New Phase III Trial Results for Rivaroxaban
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Novo Nordisk launches Changing Diabetes Barometer
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
Lipitor Demonstrated Significant Improvement or Stabilization of Kidney Function
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Bayer Temporarily Suspends Global Trasylol® Marketing
- Details
- Category: Bayer
![Bayer AG Bayer AG](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
More Pharma News ...
- Novo Nordisk celebrates 75-year commitment to diabetes research
- Taisho and Pfizer Sign a Letter of Intent for Taishoâs Schizophrenia Drug Candidate
- Tasigna® receives US approval providing new hope to chronic myeloid leukemia patients
- Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension
- Nexavar® Becomes First and Only Approved Treatment of Hepatocellular Carcinoma in Europe
- Nycomed signs definitive agreement to acquire Bradley Pharmaceuticals, Inc.
- Pfizer to Appeal German Court Decision in Lipitor Patent Case